CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 46 enrolled
Drug / intervention
Ureteroscopic lithotripsyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05218057
NCT05218057N/ACompleted
CompareCT.gov

TFL vs Ho:YAG - A Prospective Study to Compare the Effectiveness of Thulium Fiber Laser and Holmium YAG Laser for Ureteroscopic Lithotripsy

Chinese University of Hong Kong·interventional·Posted Feb 1, 2022·Updated Jan 5, 2024

In Brief

A clinical study evaluating Ureteroscopic lithotripsy for Ureteric Stone. Completed, enrolled 46 participants across 1 site.

Detailed Summary

This prospective randomized clinical trial aimed to compare the difference in stone ablation rates of TFL and Ho:YAG laser in a clinical setting. Patients are randomized to receive URS with lithotripsy (URSL) either with TFL or Ho:YAG with an allocation ratio of 1:1. Primary outcome is the efficiency of stone ablation in terms of the stone ablation rate

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUreteric Stone
CountriesHong Kong
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 1, 2022
Enrollment StartMay 1, 2022
Primary CompletionSep 29, 2023
Study CompletionOct 30, 2023
TodayJul 1, 2026
Enrollment to primary: 1.4 yearsPosted 4.4 years ago

Interventions

Ureteroscopic lithotripsyprocedure

Ureteroscopic lithotripsy is one of the surgical procedure options for ureteric stone less than 1.5 cm. While many energy systems has been used for stone fragmentation during ureteroscopy, laser energy is the most commonly used approach for stone fragmentation.